RT Journal Article
SR Electronic
T1 Classifying dementia progression using microbial profiling of saliva
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19004820
DO 10.1101/19004820
A1 P. Bathini
A1 S. Foucras
A1 A. Perna
A1 J.L. Berreux
A1 M.A. Doucey
A1 J.M. Annoni
A1 L. Alberi Auber
YR 2019
UL http://medrxiv.org/content/early/2019/08/29/19004820.abstract
AB Introduction There is increasing evidence linking periodontal infections to Alzheimer’s disease. Saliva sampling can reveal information about the host and pathogen interactions that can inform about physiological and pathological brain states.Methods A cross-sectional cohort of age-matched subjects (78) was segmented according to their chemosensory (University of Pennsylvania smell identification test; UPSIT) and cognitive scores (mini-mental score evaluation; MMSE and clinical dementia rating; CDR). Mid-morning saliva was sampled from each subject and processed for microbiome composition and cytokine analysis. Linear discriminant analysis (LDA) was used to unravel specific changes in microbial and immunological signatures and logistic regression analysis (LRA) was employed to identify taxa that varied in abundance among patients’ groups.Results Using olfaction we distinguish in the cognitively normal population a segment with high chemosensory scores (CNh, 27) and another segment with chemosensory scores (CNr, 16) as low as MCI (21) but higher than the AD group (17). We could identify stage-specific microbial signatures changes but no clear distinct cytokine profiles. Periodontal pathogen species as F. villosus decline with increasing severity of AD while opportunistic oral bacteria as L. Wadei shows a significant enrichment MCI. Conclusions: The salivary microbiome indicates stage-dependent changes in oral bacteria favoring opportunistic bacteria at the expenses of periodontal bacteria, while the inflammatory profiles remain mainly unchanged in the sampled population.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialCER-VD 2016-01627Funding StatementThis research was supported by the Swiss National Foundation (SNF-163470; LA) and EKSAS Fellowship from the Swiss Ministry of Education (PB).Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.YesI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesRaw Data available on request